title: The manufacturer's perspective.
abstract: A review of the evidence for the efficacy of a commercially available computer-aided detection (CAD) system is presented. Retrospective studies point to a potential capability of detecting approximately 20% of cancers at least 1 year earlier than normally detected by single reading of mammograms. Several prospective studies have now been published showing an actual increase of detection from 1.7% to 18%. Suggestions are given for closing the gap between the potential and actual performance with CAD, including: improving the specificity of the CAD algorithm; improving the training of end users; presenting more or better information to the radiologist; and the possible need for decision support tools.
authors.affiliation: R2 Technology, Inc, 1195 W. Fremont Ave, Sunnyvale, CA 94087, USA.
authors.forename: J
authors.initials: J
authors.lastname: Roehrig
mesh_terms: D000465:Algorithms; D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D004502:Education, Medical, Continuing; D005260:Female; D006801:Humans; D008327:Mammography / Q000379:methods*; D008403:Mass Screening / Q000379:methods; D011857:Radiographic Image Interpretation, Computer-Assisted / Q000592:standards*; D011871:Radiology / Q000193:education